SBC Medical Group Holdings Incorporated (SBCWW) Aandelenanalyse

Bedrijfsoverzicht

SBC Medical Group Holdings Incorporated, operating under the ticker SBCWW, functions as a management services provider for cosmetic treatment centers across international markets including Japan, Vietnam, the United States, and Singapore. The entity focuses on delivering advertising and marketing services via social media networks, alongside staff management solutions, though it does not have a defined sector or industry classification within the standard taxonomy. The company employs 863 individuals to support its operations, yet specific valuation metrics such as market capitalization and price-to-sales ratios are currently unavailable for public reporting. The absence of a market cap figure and the lack of a defined industry sector suggest that the company operates in a niche market or is structured in a manner that does not align with broad-based sector classifications, which limits direct comparability with large-cap peers.

Financiële gezondheid

The company reported a trailing twelve-month revenue of $173.61M, generating net income of $50.99M and EBITDA of $70.17M during the same period. The significant gap between revenue and net income reveals a cost structure where operating expenses consume approximately 70.6% of total revenue, while the EBITDA figure indicates strong operational cash generation before non-cash expenses and financing costs. Free cash flow stands at $25.41M, which provides the company with substantial financial flexibility to fund capital expenditures, repay debt obligations, or pursue strategic acquisitions without relying heavily on external financing. The gross margin is reported at 73.3%, indicating high pricing power or low cost of goods sold typical of service-based business models, while the operating margin of 32.5% and profit margin of 29.4% demonstrate effective control over overhead and tax structures. Regarding liquidity and leverage, the company holds $164.09M in cash against total debt of $51.64M, resulting in a conservative balance sheet profile supported by a debt-to-equity ratio of 19.61. Although the debt-to-equity ratio is numerically high, the substantial cash reserve significantly mitigates solvency risks. The current ratio is 3.78, which indicates robust short-term liquidity and an ability to cover current liabilities more than three times with available current assets. Return on Equity is 22.3% and Return on Assets is 13.0%, metrics that reveal management effectiveness in generating profits relative to shareholder equity and total asset base respectively.

Waarderingsbeoordeling

Trailing P/E and forward P/E ratios are listed as N/A in the available data, meaning that standard earnings-based valuation multiples cannot be calculated or compared against historical norms for this specific reporting period. The price-to-book ratio is 0.11, which indicates that the market values the company's equity at a fraction of its book value, suggesting the market may be undervaluing the firm's assets or anticipating future challenges. Price-to-sales and EV/EBITDA multiples are also unavailable, preventing an assessment of valuation relative to revenue generation or enterprise value adjusted for earnings. The stock traded between a 52-week high of $0.27 and a 52-week low of $0.26, meaning the current price sits within a very narrow trading range with minimal fluctuation over the last year. The beta value is 0.99, which implies that the stock's price volatility moves in tandem with the broader market, exhibiting neither significant defensive characteristics nor aggressive growth sensitivity.

Growth & Income

Revenue growth year-over-year declined by 10.9%, while earnings growth year-over-year surged by 117.5%, indicating that earnings are growing at a significantly faster rate than revenue, likely due to cost-cutting measures or non-recurring income recognition. The company does not pay a dividend, as indicated by the N/A status for both dividend yield and payout ratio, which means the entity retains all generated earnings to reinvest into business operations or to bolster its cash reserves. This retention strategy prioritizes internal growth and balance sheet strengthening over income distribution to shareholders. Overall, the company presents a profile characterized by a contraction in top-line revenue offset by a dramatic expansion in profitability, supported by a highly liquid balance sheet and a lack of dividend obligations.